反应详情

To 2-(difluoro(5-fluoropyridin-2-yl)methyl)-4-(methylthio)quinazoline-8-carboxamide (191 mg, 0.52 mmol) in DCM (8 mL) at 0° C. was added 3-chloroperbenzoic acid (70%, 192 mg, 0.78 mmol) and the mixture was stirred for 90 min. The mixture was diluted with DCM and then aq sodium thiosulfate was added, followed by addition of saturated aq sodium bicarbonate. The organic layer was dried over sodium sulfate and concentrated under reduced pressure. To the residue were added THF (5 mL) and 5-methyl-1H-pyrazol-3-amine (153 mg, 1.58 mmol) and the mixture was stirred at rt for 15 min. The mixture was concentrated under reduced pressure and purified by preparative HPLC (Varian diphenyl reverse phase column, eluted with gradient of solvent B=0.05% AcOH/ACN and solvent A=5% ACN/0.05% AcOH/H2O) to afford 2-(difluoro(5-fluoropyridin-2-yl)methyl)-4-((5-methyl-1H-pyrazol-3-yl)amino)quinazoline-8-carboxamide (108 mg, 50%). 1H NMR (300 MHz, DMSO-d6) δ ppm 2.20 (s, 3H) 6.08 (s, 1H) 7.76 (t, J=7.82 Hz, 1H) 7.92 (d, J=3.39 Hz, 1H) 7.98-8.11 (m, 2H) 8.58-8.75 (m, 2H) 8.89 (d, J=7.54 Hz, 1H) 9.91 (d, J=3.20 Hz, 1H) 10.80-11.38 (m, 1H) 12.17 (br s, 1H); LC-MS (ESI) m/z 414 (M+H)+.

1. dry with materialThe organic layer was dried over sodium sulfate
2. concentrationconcentrated under reduced pressure
3. stirringthe mixture was stirred at rt for 15 min
4. concentrationThe mixture was concentrated under reduced pressure
5. custompurified by preparative HPLC (Varian diphenyl reverse phase column
6. washeluted with gradient of solvent B=0.05% AcOH/ACN and solvent A=5% ACN/0.05% AcOH/H2O)